Latest Human Genome Sciences Stories

LONDON, February 12, 2013 /PRNewswire/ -- Any drug company's stock price hinges on the performance of its drugs. One of the very first steps involved in marketing a drug is getting the approval of FDA. Dynavax Technologies Corporation (NASDAQ: DVAX) is one such company that pointed out that the point recently. The stock plummeted when its drug candidate received poor reviews. However, the same Hepatitis B drug is now waiting for the final approval and the FDA's decision will...

LONDON, Dec. 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate. The effectiveness of raxibacumab is based solely on...

BONITA SPRINGS, Fla., Nov. 14, 2012 /PRNewswire-iReach/ -- VR Laboratories LLC today announced the appointment of Robert Haynes as Senior Vice President, Product Introduction and Licensing. Haynes brings more than 25 years of management and executive experience in pharmaceutical and biotechnology product development, partnering, and global commercialization. Most recently, Haynes led the Alliance Management and New Product Planning departments at Human Genome Sciences (HGS). At HGS...

Lawrence LeBlond for redOrbit.com - Your Universe Online British pharmaceutical giant GlaxoSmithKline (GSK) has acquired US-based Human Genome Sciences (HGS) after tough negotiations saw it raise offers from an initial $2.6 billion in April, putting the final value of the deal at $3.6 billion or $14.25 per share. By securing HGS, GSK is gaining full control of the drug Benlysta, the first drug in more than 50 years to be approved by the Food and Drug Administration (FDA) for the...

VANCOUVER, British Columbia, July 17, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Human Genome Sciences (NASDAQ:HGSI), Hewlett-Packard (NYSE:HPQ), Visa (NYSE:V), Par Pharmaceutical (NYSE:PRX), Nokia (NYSE:NOK), and SandRidge Energy (NYSE:SD). (Logo: http://photos.prnewswire.com/prnh/20120531/HK16417LOGO ) (Read full report by clicking the link below, you may need to copy and paste...

Patients, caregivers face significant financial and professional challenges ROCKVILLE, Md. and RESEARCH TRIANGLE PARK, N.C., July 11, 2012 /PRNewswire-USNewswire/-- Results of a Roper survey of the lupus community highlight that in addition to the physical burdens of lupus, the disease can contribute to significant economic challenges among patients and caregivers. Patients with systemic lupus erythematosus (SLE or lupus), caregivers and physicians overwhelmingly agree that career...

ROCKVILLE, Md. and RESEARCH TRIANGLE PARK, N.C., May 10, 2012 /PRNewswire-USNewswire/ -- Launching today in celebration of World Lupus Day and Lupus Awareness Month, Lupus Out Loud (www.lupusoutloud.com) is a new online movement and video developed to encourage people with lupus to speak "out loud" about their symptoms. The movement was inspired by the results of a recent Roper survey in which over half (52 percent) of patients with lupus surveyed reported that they minimize their...

VANCOUVER, British Columbia, April 20, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Human Genome Sciences (NASDAQ:HGSI), Gilead Sciences (NASDAQ:GILD), Bristol Myers Squibb (NYSE:BMY), CVR Energy (NYSE:CVI), UnitedHealth Group (NYSE:UNH), and US Airways Group (NYSE:LCC). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste...

VANCOUVER, British Columbia, April 2, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Finish Line (NASDAQ:FINL), Corning (NYSE:GLW), Interpublic Group of Companies (NYSE:IPG), Patriot Coal (NYSE:PCX), Marvell (NASDAQ:MRVL), and Human Genome Sciences (NASDAQ:HGSI). (Logo: http://photos.prnewswire.com/prnh/20120307/HK65974LOGO ) (Read full report by clicking the link below, you may need to copy and...

PRINCETON, N.J., March 27, 2012 /PRNewswire/ -- Laureate Biopharmaceutical Services, Inc., a full-service biopharmaceutical contract development and manufacturing organization, today announced the appointment of Lisa Cozza as Vice President, Business Development and member of the Management Committee. (Logo: http://photos.prnewswire.com/prnh/20120214/PH53290LOGO ) Ms. Cozza will report directly to Michael A. Griffith, Chief Executive Officer. "Lisa is highly regarded in the...